Mangalam Drugs and Organics Ltd

Mangalam Drugs and Organics Ltd | Sector: Pharmaceuticals | ISIN: INE584F01014

₹ 98.00 (-0.25%) icon

31 Mar, 2023, 3:46:25 PM
Open
₹ 97.00
Prev. Close
₹ 98.25
Turnover(lac)
₹ 39.31
Day's High
₹ 103.35
Day's Low
₹ 97.00
52 Wk High
₹ 173.00
52 Wk Low
₹ 95.25
Book Value
₹ 98.70
Face Value
₹ 10.00
Mkt. Cap (Cr.)
₹ 155.12
P/E
12.54
EPS
7.80
Div. Yield
0.00

KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 3/31/2023 3:46:25 PM

    ₹ 98 -0.25 -0.25
  • Open
  • ₹ 97
  • Prev. Close
  • ₹ 98.25
  • Turnover(Lac.)
  • ₹ 39
  • Day's High
  • ₹ 103.35
  • Day's Low
  • ₹ 97
  • 52 Week's High
  • ₹ 173
  • 52 Week's Low
  • ₹ 95.25
  • Book Value
  • ₹ 98.7
  • Face Value
  • ₹ 10
  • Mkt Cap (₹ Cr.)
  • 155.12
  • P/E
  • 12.54
  • EPS
  • 7.8
  • Divi. Yield
  • 0

Corporate Actions

29 Mar , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

06 Feb , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

06 Feb , 2023

12:00 AM

04 Nov , 2022

12:00 AM

04 Nov , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

05 Sep , 2022

12:00 AM

AGM

Announcement date: 05 Sep , 2022

View Details

26 Aug , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

29 Jul , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

29 Jul , 2022

12:00 AM

18 May , 2022

12:00 AM

18 May , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

SHAREHOLDING SNAPSHOT
02 April , 2023 | 02:03 AM

PROMOTER - TOTAL50.32%

Indian: 50.32%

Foreign: 0%

NON-PROMOTER - TOTAL 49.68%

Institutions: 0.10%

Non-Institutions: 49.58%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Mangalam Drugs and Organics Ltd News and Update

Article Image
  • 1 day ago |
  • 4:14 PM

The company said it made amendments to ESOP, which had been approved by both the board and shareholders earlier in the month.

Image not found
Article Image
  • IIFL News Service |
  • 1 day ago |
  • 4:13 PM
Article Image
  • IIFL News Service |
  • 1 day ago |
  • 4:13 PM
ad IconAd Image

FINANCIALS

No Data Available To Display Chart

PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Mangalam Drugs and Organics Ltd

  • Govardhan M Dhoot

  • Chairman & Managing Director
  • Brijmohan Dhoot

  • Whole-time Director
  • Rukmesh P. Dhandhania

  • Independent Director
  • Nidhi S. Mundada

  • Independent Director
  • Praveen Saxena

  • Independent Director
  • Jayant Barde

  • Company Sec. & Compli. Officer
  • Rakesh K. Milwani

  • Director

Summary

Mangalam Drugs and Organics Ltd is an India-based company. The company is engaged in the manufacturing of chemicals, such as active pharma ingredients (API) perfumery, disperse dye intermediates, bulk drugs and bulk drugs intermediates. The company has their manufacturing facilities at Vapi in Gujarat and Sangamner in Maharashtra. They also have an in-house Research and Development (R&D) Base. Their products include chloroquine phosphate I.P., aluminum chloride anhydrous, and dyes and intermediaries.Mangalam Drugs and Organics Ltd was incorporated on April 18, 1972 as a private limited company with the name Advent Pharma Pvt Ltd. The company was promoted by Dhoot family. The company was established with a view to set up a plant for manufacture of organic and inorganic chemicals.In April 1, 1996 three other group companies, namely Mangalam Organics Pvt Ltd, Shree Mangalam Pharma Pvt Ltd and Mangalam Rasayan Pvt Ltd were amalgamated with the company. In July 1, 1997, the company changed their name from Advent Pharma Pvt Ltd to Mangalam Drugs and Organics Pvt Ltd. In September 22, 1997, the company was converted into a deemed public company and word private was deleted from the companys name. In the year 1999, the company launched a new product namely, Nimesulide. In the year 2001, they launched two new products namely Amodiaquine Hydrochloride and Amodiaquine. In August 10, 2001, the company was converted into a full fledged public limited company.In the year 2003-2004, the... Read More


Reports by Mangalam Drugs and Organics Ltd


Reports by Mangalam Drugs and Organics Ltd